— Marc Skalla, President, SASCO Chemical
— Rusty Skalla, COO, SASCO Chemical
"We are very pleased with the transaction and our new partnership. We engaged Genesis Capital to help our physician owners consider our strategic options, particularly in light of the increasingly complex healthcare landscape. Genesis Capital was invaluable in helping us secure the best partner for Optim, which enables us to remain physician-focused, provides the management support and resources to continue to grow and operate effectively, and, most importantly, enables us to continue to provide patients with the highest quality care in Southeast Georgia."
— Dr. John George, Lead Physician Partner, Optim
“Genesis Capital was integral to the execution of Polytek’s acquisition growth strategy. Their expertise was paramount to our successful closing of three acquisitions, helping Polytek unlock substantial growth both within its product lines as well as geographically. Further, Genesis Capital’s knowledge of the acquirer landscape for Polytek allowed us to build the business with an eye towards this successful sale to Arsenal Capital.”
— Graham Schena, Partner, MPE